Nanjing Vazyme Biotech Co Ltd (688105) — Net Asset Quality Index
Nanjing Vazyme Biotech Co Ltd (688105) has a Net Asset Quality Index of 77.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.63 Billion minus total liabilities of CN¥1.03 Billion yields net assets of CN¥3.60 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of Nanjing Vazyme Biotech Co Ltd for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Nanjing Vazyme Biotech Co Ltd Net Asset Quality Index Over Time (2017–2025)
This chart shows how Nanjing Vazyme Biotech Co Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 77.8%, representing net assets of CN¥3.60 Billion against total assets of CN¥4.63 Billion CNY. For live market cap and overall valuation, see 688105 stock market capitalisation.
Annual Net Asset Quality Index for Nanjing Vazyme Biotech Co Ltd (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Nanjing Vazyme Biotech Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Nanjing Vazyme Biotech Co Ltd (688105) net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 75.4% | CN¥3.79 Billion | CN¥5.03 Billion | CN¥1.24 Billion | ▼ -2.7 pp |
| 2024 | 78.1% | CN¥3.94 Billion | CN¥5.05 Billion | CN¥1.11 Billion | ▲ +8.0 pp |
| 2023 | 70.1% | CN¥4.03 Billion | CN¥5.75 Billion | CN¥1.72 Billion | ▼ -6.7 pp |
| 2022 | 76.8% | CN¥4.61 Billion | CN¥6.01 Billion | CN¥1.39 Billion | ▼ -12.8 pp |
| 2021 | 89.6% | CN¥4.13 Billion | CN¥4.61 Billion | CN¥479.83 Million | ▲ +6.9 pp |
| 2020 | 82.7% | CN¥1.33 Billion | CN¥1.61 Billion | CN¥279.28 Million | ▲ +21.0 pp |
| 2019 | 61.7% | CN¥200.02 Million | CN¥324.33 Million | CN¥124.31 Million | ▼ -4.6 pp |
| 2018 | 66.2% | CN¥166.08 Million | CN¥250.75 Million | CN¥84.67 Million | ▼ -13.8 pp |
| 2017 | 80.1% | CN¥150.82 Million | CN¥188.40 Million | CN¥37.57 Million | — |